loading

Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
21.93%
9.04
7.414 7.151 6.385 7.105
Operating Income/Loss
21.93%
-9.04
-7.414 -7.151 -6.385 -7.105
Income/Loss From Continuing Operations Before Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Net Income/Loss
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Diluted Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Basic Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Diluted Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.54
price up icon 0.86%
$22.91
price up icon 7.03%
$32.48
price up icon 2.06%
$102.71
price up icon 0.62%
$166.05
price up icon 2.27%
biotechnology ONC
$331.09
price up icon 3.38%
Capitalizzazione:     |  Volume (24 ore):